The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Leukemia Propagating Cells Rebuild an Evolving Niche in Response to Therapy
Open accessAbstract
Residence of cancer-propagating cells (CPCs) within preferential microenvironmental niches has a major part in evading therapy. However, the nature of niches involved and the mechanisms protecting CPCs remain largely unknown. We addressed these issues in mouse transplantation models of acute lymphoblastic leukemia (ALL). When the engrafted leukemic cells substantially damaged adjacent microenvironment in the bone marrow (BM), after chemotherapy small foci of CPCs were retained, surrounded by sheaths of supporting cells that comprise a protective niche. We investigated patients' BM biopsies and found evidence of a similar process in patients receiving induction therapy. The efficacy of chemotherapy was enhanced by interfering with the niche formation or function. We therefore identified a therapy-induced niche that protects CPCs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These altered cells are difficult to eliminate by conventional antitumoral agents because drugs do not reach the bone marrow at the required concentration, and because the stem cell niche (a physical and functional entity that supports the self-renewal and differentiation of stem cells) changes/adapts after chemotherapy, protecting altered cells97.”
From Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine (2020) · cites this paper as [97]
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Osteoblastic cells regulate the haematopoietic stem cell niche
Calvi, L. M., Adams, G. B., Weibrecht, K. W., Weber, J. M., Olson, D. P., Knight, M. C., Martin, R. P., Schipani, E., Pajevic, P. D., Bringhurst, F. R., et al. (2003) · Nature · doi:10.1038/nature02040 · Cited by 3,559
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
Méndez‐Ferrer, S., Michurina, T. V., Ferraro, F., Mazloom, A. R., MacArthur, B. D., Lira, S. A., Scadden, D. T., Ma’ayan, A., Enikolopov, G., & Frenette, P. S. (2010) · Nature · doi:10.1038/nature09262 · Cited by 3,381
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Identification of the haematopoietic stem cell niche and control of the niche size
Zhang, J., Niu, C. S., Ye, L., Huang, H., He, X. C., Tong, W.-G., Ross, J., Haug, J., Johnson, T. J., Feng, J. Q., et al. (2003) · Nature · doi:10.1038/nature02041 · Cited by 2,948
Self-citationA Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey, J. K., Young, M. A., Lamprecht, T., McLellan, M. D., et al. (2012) · Nature · doi:10.1038/nature10738 · Cited by 1,993
Bone-marrow haematopoietic-stem-cell niches
Wilson, A., & Trumpp, A. (2006) · Nature reviews. Immunology · doi:10.1038/nri1779 · Cited by 1,420
Arteriolar niches maintain haematopoietic stem cell quiescence
Kunisaki, Y., Bruns, I., Scheiermann, C., Ahmed, J. U., Pinho, S., Zhang, D., Mizoguchi, T., Wei, Q., Lucas, D., Ito, K., et al. (2013) · Nature · doi:10.1038/nature12612 · Cited by 1,290
Ishikawa, F., Yoshida, S., Saito, Y., Hijikata, A., Kitamura, H., Tanaka, S., Nakamura, R., Tanaka, T., Tomiyama, H., Saito, N., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1350 · Cited by 1,025
Cited by
Sorted by citations
Tumor microenvironment: Sanctuary of the devil
Hui, L., & Chen, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.039 · Cited by 797
Microenvironmental regulation of therapeutic response in cancer
Klemm, F., & Joyce, J. A. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.006 · Cited by 795
New horizons in tumor microenvironment biology: challenges and opportunities
Chen, F., Zhuang, X., Lin, L., Yu, P., Wang, Y., Shi, Y., Hu, G., & Sun, Y. (2015) · BMC Medicine · doi:10.1186/s12916-015-0278-7 · Cited by 704
Tumor microenvironment and cancer therapy resistance
Sun, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.044 · Cited by 391
Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML
Duarte, D., Hawkins, E. D., Akinduro, O., Ang, H. Y.-K., Filippo, K. D., Kong, I. Y., Haltalli, M. L. R., Ruivo, N., Straszkowski, L., Vervoort, S. J., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.11.006 · Cited by 328
Therapy resistance mediated by cancer stem cells
Steinbichler, T. B., Dudás, J., Skvortsov, S., Ganswindt, U., Riechelmann, H., & Skvortsova, I. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.006 · Cited by 298
Burt, R. J., Dey, A., Aref, S., Aguiar, M., Akarca, A. U., Bailey, K., Day, W. P., Hooper, S., Kirkwood, A. A., Kirschner, K., et al. (2019) · Blood · doi:10.1182/blood.2019001398 · Cited by 249
The hematopoietic stem cell niche in homeostasis and disease
Calvi, L. M., & Link, D. C. (2015) · Blood · doi:10.1182/blood-2015-07-533588 · Cited by 238
T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments
Hawkins, E. D., Duarte, D., Akinduro, O., Khorshed, R., Passaro, D., Nowicka, M., Straszkowski, L., Scott, M., Rothery, S., Ruivo, N., et al. (2016) · Nature · doi:10.1038/nature19801 · Cited by 208
Bone metastasis and the metastatic niche
Ren, G., Esposito, M., & Kang, Y. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1329-4 · Cited by 167
Zheng, H., Bae, Y., Kasimir‐Bauer, S., Tang, R. B., Chen, J., Ren, G., Yuan, M., Esposito, M., Li, W., Wei, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.11.002 · Cited by 163
Self-citationEpidemiology and biology of relapse after stem cell transplantation
Horowitz, M. M., Schreiber, H. W., Elder, A., Heidenreich, O. T., Vormoor, J. H., Toffalori, C., Vago, L., & Kröger, N. M. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0171-z · Cited by 156
Zhao, M., Tao, F., Venkatraman, A., Li, Z., Smith, S. E., Unruh, J., Chen, S., Ward, C., Qian, P., Perry, J. M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.093 · Cited by 146
Self-citationAdvances and challenges in retinoid delivery systems in regenerative and therapeutic medicine
Ferreira, R., Napoli, J., Enver, T., Bernardino, L., & Ferreira, L. (2020) · Nature Communications · doi:10.1038/s41467-020-18042-2 · Cited by 138
Self-citationThe interplay of leukemia cells and the bone marrow microenvironment
Duarte, D., Hawkins, E. D., & Celso, C. L. (2018) · Blood · doi:10.1182/blood-2017-12-784132 · Cited by 135
Losing Sense of Self and Surroundings: Hematopoietic Stem Cell Aging and Leukemic Transformation
Verovskaya, E. V., Dellorusso, P. V., & Passegue, E. A. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.04.006 · Cited by 130
The hematopoietic stem-cell niche in health and leukemia
Sánchez‐Aguilera, A., & Méndez‐Ferrer, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2306-y · Cited by 119
Akinduro, O., Weber, T., Ang, H. Y.-K., Haltalli, M. L. R., Ruivo, N., Duarte, D., Rashidi, N. M., Hawkins, E. D., Duffy, K. R., & Celso, C. L. (2018) · Nature Communications · doi:10.1038/s41467-017-02376-5 · Cited by 97
A hostel for the hostile: the bone marrow niche in hematologic neoplasms
Krause, D. S., & Scadden, D. T. (2015) · Haematologica · doi:10.3324/haematol.2014.113852 · Cited by 104
Mammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis
Yip, R. K. H., Rimes, J. S., Capaldo, B. D., Vaillant, F., Mouchemore, K. A., Pal, B., Chen, Y., Surgenor, E. E., Murphy, A. J., Anderson, R. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26556-6 · Cited by 105
Engineering chimeric antigen receptor-T cells for cancer treatment
Ye, B., Stary, C. M., Li, X., Gao, Q., Kang, C., & Xiong, X. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0814-0 · Cited by 95
Ma, C., Witkowski, M. T., Harris, J., Dolgalev, I., Sreeram, S., Qian, W., Tong, J., Chen, X., Aifantis, I., & Chen, W. (2020) · Science Advances · doi:10.1126/sciadv.aba5536 · Cited by 97
Xie, C., Yang, Z., Suo, Y., Chen, Q., Wei, D., Weng, X., Gu, Z., & Wei, X. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0204 · Cited by 85
Rouger, J., Jakobczyk, H., Debaize, L., Cousin, É., Galibert, M., Troadec, M., & Gandemer, V. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.04.003 · Cited by 76
Hu, X., Mei, S., Meng, W., Xue, S., Jiang, L., Yang, Y., Hui, L., Chen, Y., & Guan, M. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.03.024 · Cited by 73
Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models
He, X., Wan, J., Yang, X., Zhang, X., Huang, D., Xie, L., Zou, Y., Chen, C., Yu, Z., Xie, L., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140242 · Cited by 70
Self-citationKong, Y., Wang, Y., Zhang, Y., Shi, M.-M., Mo, X., Sun, Y., Chang, Y., Xu, L., Zhang, X., Liu, K., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018029454 · Cited by 67
Kong, Y., Cao, X.-N., Zhang, X., Shi, M.-M., Lai, Y., Wang, Y., Xu, L., Chang, Y., & Huang, X. (2017) · Blood · doi:10.1182/blood-2017-09-807248 · Cited by 65
Hao, X., Gu, H., Chen, C., Huang, D., Zhao, Y., Xie, L., Zou, Y., Shu, H. S., Zhang, Y., He, X., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.11.013 · Cited by 67
Self-citationChen, C., Hao, X., Lai, X., Liu, L., Zhu, J., Shao, H., Huang, D., Gu, H., Zhang, T., Yu, Z., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd6280 · Cited by 63
The Bone Marrow Microenvironment in Health and Myeloid MalignancyPreprint
Galán-Díez, M., Cuesta‐Domínguez, Á., & Kousteni, S. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031328 · Cited by 59
Transmissible ER stress reconfigures the AML bone marrow compartment
Doron, B., Abdelhamed, S., Butler, J. T., Hashmi, S. K., Horton, T. M., & Kurre, P. (2018) · Leukemia · doi:10.1038/s41375-018-0254-2 · Cited by 59
Glait‐Santar, C., Desmond, R. G., Feng, X., Bat, T., Chen, J., Heuston, E. F., Mizukawa, B. E., Mulloy, J. C., Bodine, D. M., Larochelle, A., et al. (2015) · Stem Cells · doi:10.1002/stem.2208 · Cited by 55
Self-citationPal, D., Blair, H., Elder, A., Dormon, K., Rennie, K., Coleman, D. J. L., Weiland, J., Rankin, K. S., Filby, A. J., Heidenreich, O. T., et al. (2016) · Leukemia · doi:10.1038/leu.2016.79 · Cited by 55
Hou, D., Wang, B., You, R., Wang, X., Liu, J., Zhan, W., Chen, P., Qin, T., Zhang, X., & Huang, H. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-3191 · Cited by 59
Self-citationChemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse
Yang, F., Brady, S. W., Tang, C. S., Sun, H., Du, L., Barz, M., Ma, X., Chen, Y., Fang, H., Li, X., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00230-8 · Cited by 55
Self-citationZhai, Y., Zhang, J., Wang, H., Lu, W., Liu, S., Yu, Y., Weng, W., Ding, Z., Zhu, Q., & Shi, J. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0405-0 · Cited by 51
Self-citationInfluence of Bone Marrow Microenvironment on Leukemic Stem Cells
Agarwal, P., & Bhatia, R. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.04.007 · Cited by 51
Dong, X., Mu, L., Liu, X., Zhu, H., Yang, S., Lai, X. P., Liu, H., Feng, H., Lu, Q., Zhou, B. S., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000309 · Cited by 51
Self-citationThe Osteoblastic Niche in Hematopoiesis and Hematological Myeloid Malignancies
Galán-Díez, M., & Kousteni, S. (2017) · Current Molecular Biology Reports · doi:10.1007/s40610-017-0055-9 · Cited by 53
Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia
Elder, A., Bomken, S. N., Wilson, I., Blair, H., Cockell, S., Ponthan, F., Dormon, K., Pal, D., Heidenreich, O. T., & Vormoor, J. H. (2017) · Leukemia · doi:10.1038/leu.2017.140 · Cited by 49
Kong, Y., Shi, M., Zhang, Y., Cao, X.-N., Wang, Y., Zhang, X., Xu, L., & Huang, X. (2018) · American Journal of Hematology · doi:10.1002/ajh.25056 · Cited by 47
Immature CML cells implement a BMP autocrine loop to escape TKI treatment
Grockowiak, É., Laperrousaz, B., Jeanpierre, S., Voeltzel, T., Guyot, B., Gobert, S., Nicolini, F. E., & Maguer‐Satta, V. (2017) · Blood · doi:10.1182/blood-2017-08-801019 · Cited by 46
Mapping and targeting of the leukemic microenvironment
Witkowski, M. T., Kousteni, S., & Aifantis, I. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190589 · Cited by 47
Translational models of tumor angiogenesis: A nexus of in silico and in vitro models
Soleimani, S., Shamsi, M., Ghazani, M. A., Modarres, H. P., Valente, K. P., Saghafian, M., Ashani, M. M., Akbari, M., & Sanati‐Nezhad, A. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.01.013 · Cited by 43
Zhao, H., Lyu, Z., Duan, C., Song, Y., Han, T., Mo, X., Wang, Y., Xu, L., Zhang, X., Huang, X., et al. (2018) · British Journal of Haematology · doi:10.1111/bjh.15452 · Cited by 43
Self-citationHeydt, Q., Xintaropoulou, C., Clear, A. J., Austin, M. J., Pislariu, I., Miraki‐Moud, F., Cutillas, P. R., Korfi, K., Calaminici, M., Cawthorn, W. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25540-4 · Cited by 43
Lu, W., Wan, Y., Li, Z., Zhu, B., Yin, C., Liu, H., Yang, S., Zhai, Y., Yu, Y., Wei, Y., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0738-y · Cited by 41
Self-citationTherapeutic Antibodies for Myeloid Neoplasms—Current Developments and Future Directions
Schürch, C. M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00152 · Cited by 42
Woods, K., & Guezguez, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.714716 · Cited by 42
Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth
Kellaway, S. G., Potluri, S., Keane, P., Blair, H. J., Ames, L., Worker, A., Chin, P. S., Ptasinska, A., Derevyanko, P. K., Adamo, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45691-4 · Cited by 40
Wang, Y., Yang, X., Sun, X., Rong, L., Kang, M., Wu, P., Ji, X., Lin, R., Huang, J., Xue, Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1078-8 · Cited by 38
Li, J., Volk, A. G., Zhang, J., Cannova, J., Dai, S., Hao, C., Hu, C.-L., Sun, J., Xu, Y., Wei, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14220 · Cited by 38
Self-citationThe BMP pathway: A unique tool to decode the origin and progression of leukemia
Zylbersztejn, F., Flores-Violante, M., Voeltzel, T., Nicolini, F. E., Lefort, S., & Maguer‐Satta, V. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.02.005 · Cited by 38
Chen, Y., Tang, C. S., Zhang, M., Huang, W., Xu, Y. K., Sun, H.-Y., Yang, F., Song, L., Wang, H., Mu, L., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0458-0 · Cited by 37
Self-citationBone marrow microenvironment modulation of acute lymphoblastic leukemia phenotype
Moses, B. S., Slone, W. L., Thomas, P., Evans, R., Piktel, D., Angel, P. M., Walsh, C. M., Cantrell, P. S., Rellick, S. L., Martin, K. H., et al. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.09.003 · Cited by 37
Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice
Gopalakrishnapillai, A., Kolb, E. A., Dhanan, P., Bojja, A. S., Mason, R. W., Corao, D., & Barwe, S. P. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00162 · Cited by 37
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias
Pietra, G., Vitale, C., Pende, D., Bertaina, A., Moretta, F., Falco, M., Vacca, P., Montaldo, E., Cantoni, C., Mingari, M. C., et al. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1744-y · Cited by 36
Velázquez-Avila, M., Balandrán, J. C., Ramírez-Ramírez, D., Velázquez-Avila, M., Sandoval-Cabrera, A., Felipe‐López, A., Nava, P., Alvarado‐Moreno, J. A., Dozal, D., Prieto‐Chávez, J. L., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0333-4 · Cited by 36
THBS1 Is a Novel Serum Prognostic Factors of Acute Myeloid Leukemia
Zhu, L., Li, Q., Wang, X., Liao, J., Zhang, W., Gao, L., Liu, Y. Z., Zhang, C., Zhang, X., Rao, J., et al. (2019) · Frontiers in Oncology · doi:10.2139/ssrn.3401979 · Cited by 35
Fan, H., Xu, Z., Yao, K., Zheng, B., Zhang, Y., Wang, X., Zhang, T., Li, X., Hu, H., Yue, B., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1443 · Cited by 40
Boutter, J., Huang, Y., Marovca, B., Vonderheit, A., Grotzer, M. A., Eckert, C., Cario, G., Wollscheid, B., Horváth, P., Bornhauser, B. C., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2572 · Cited by 35
Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop
Fahy, L., Calvo, J., Chabi, S., Renou, L., Maout, C. L., Poglio, S., Leblanc, T. M., Petit, A., Baruchel, A., Ballerini, P. F., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002832 · Cited by 35
Shu, Y., Wang, Y., Lv, W.-Q., Peng, D.-Y., Li, J., Zhang, H., Jiang, G.-J., Yang, B.-J., Liu, S., Zhang, J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1471 · Cited by 34
TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment
Le, B. V., Podszywalow‐Bartnicka, P., Maifrede, S., Sullivan-Reed, K., Nieborowska-Skorska, M., Golovine, K. V., Yao, J.-C., Nejati, R., Cai, K. Q., Caruso, L. B., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108221 · Cited by 31
Park, C. S., Yoshihara, H., Gao, Q., Qu, C., Iacobucci, I., Ghate, P. S., Connelly, J. P., Pruett‐Miller, S. M., Wagner, B., Robinson, C. G., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112804 · Cited by 31
Liu, J., Masurekar, A. N., Johnson, S. M., Chakraborty, S., Griffiths, J., Smith, D. L., Alexander, S., Dempsey, C. E., Parker, C. A., Harrison, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5528 · Cited by 30
Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment
Montoya, M. M., van Slobbe, G. J. J., Chang, J., Zaal, E. A., & Berkers, C. R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1155621 · Cited by 33
Pan, C., Fang, Q., Liu, P., Ma, D., Cao, S., Zhang, L., Chen, Q., Hu, T., & Wang, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.708513 · Cited by 29
Boto, C., Quartin, E., Cai, Y., Martín-Lorenzo, A., Cenador, M. B. G., Pinto, S., Gupta, R., Enver, T., Sánchez-García, I., Hong, D., et al. (2017) · Nature Communications · doi:10.1038/ncomms15204 · Cited by 28
Self-citationA non-cell-autonomous role for Pml in the maintenance of leukemia from the niche
Guarnerio, J., Mendez, L., Asada, N., Menon, A. V., Fung, J., Berry, K., Frenette, P. S., Ito, K., & Pandolfi, P. P. (2017) · Nature Communications · doi:10.1038/s41467-017-02427-x · Cited by 27
Vanegas, N.-D. P., Ruiz-Aparicio, P. F., Uribe, G. I., Ballesteros, A. L., & Vernot, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158166 · Cited by 26
Tang, C. S., Li, M., Chen, Y., Sun, H., Liu, S.-L., Zheng, W., Zhang, M., Li, H., Fu, W. E., Zhang, W., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0859-3 · Cited by 27
Self-citationTumor–Stroma Interactions in Bone Metastasis: Molecular Mechanisms and Therapeutic ImplicationsPreprint
Zheng, H., Li, W., & Kang, Y. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030775 · Cited by 25
Shlush, L. I., & Minden, M. D. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000111 · Cited by 25
Delahaye, M. C., Salem, K.-I., Pelletier, J., Aurrand‐Lions, M., & Mancini, S. J. C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.606540 · Cited by 29
Concise Review: The Malignant Hematopoietic Stem Cell Niche
Yao, J.-C., & Link, D. C. (2016) · Stem Cells · doi:10.1002/stem.2487 · Cited by 26
Giallongo, S., Duminuco, A., Dulcamare, I., Zuppelli, T., Spina, E. L., Scandura, G., Santisi, A., Romano, A., Raimondo, F. D., Tibullo, D., et al. (2023) · Biomolecules · doi:10.3390/biom13121701 · Cited by 24
Tumoral reprogramming: Plasticity takes a walk on the wild side
Campos‐Sánchez, E., & Cobaleda, C. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.07.003 · Cited by 24
Cao, X.-N., Kong, Y., Song, Y., Shi, M., Zhao, H., Wen, Q., Lyu, Z., Duan, C., Wang, Y., Xu, L., et al. (2018) · British Journal of Haematology · doi:10.1111/bjh.15456 · Cited by 23
Self-citationLiu, Y., Wu, Y., Zhang, P., Xu, C., Liu, Z., He, C., Liu, Y.-M., & Kang, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.636870 · Cited by 22
Liu, H., Zhai, Y., Zhao, W., Wan, Y., Lu, W., Yang, S., Yu, Y., Wei, Y., Li, Z., & Shi, J. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488225 · Cited by 22
Self-citationAiding and Abetting: How the Tumor Microenvironment Protects Cancer from Chemotherapy
Fiedler, E. C., & Hemann, M. T. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055524 · Cited by 22
Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms
Valent, P., Sadovnik, I., Eisenwort, G., Herrmann, H., Bauer, K., Mueller, N., Sperr, W. R., Wicklein, D., & Schumacher, U. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.025 · Cited by 21
Georgievski, A., Michel, A., Thomas, C., Mlamla, Z. C., de Barros, J.-P. P., Lemaire‐Ewing, S., Garrido, C., & Quéré, R. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04761-5 · Cited by 22
Metabolic crosstalk between stromal and malignant cells in the bone marrow niche
Tirado, H. A., Balasundaram, N., Laaouimir, L., Erdem, A., & van Gastel, N. (2023) · Bone Reports · doi:10.1016/j.bonr.2023.101669 · Cited by 25
BERNASCONI, P. P., Farina, M., Boni, M., Dambruoso, I., & Calvello, C. (2016) · American Journal of Hematology · doi:10.1002/ajh.24312 · Cited by 22
Vanegas, N.-D. P., & Vernot, J. (2017) · Experimental Hematology and Oncology · doi:10.1186/s40164-016-0062-1 · Cited by 23
Senft, D., & Jeremias, I. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.09.006 · Cited by 23
Can Dendritic Cell Vaccination Prevent Leukemia Relapse?
O’Brien, L., Guillerey, C., & Radford, K. J. (2019) · Cancers · doi:10.3390/cancers11060875 · Cited by 21
SUMOylation of sPRDM16 promotes the progression of acute myeloid leukemia
Dong, S., & Chen, J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1844-2 · Cited by 20
Self-citationThe molecular signature of AML with increased ALDH activity suggests a stem cell origin
Blume, R., Rempel, E., Manta, L., Saeed, B. R., Wang, W., Raffel, S., Ermakova, O. V., Eckstein, V., Beneš, V., Trumpp, A., et al. (2018) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1422862 · Cited by 20
Smart on-demand drug release strategies for cancer combination therapy
Huang, X., Ji, M., Shang, X., Zhang, H., Zhang, X., Zhou, J., & Yin, T. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113782 · Cited by 19
Pal, D., Blair, H. J., Boyd, S., Sharon, A. H., Nizami, S., Isa, A., Beckett, M., Nelson, R., Wilson, A., Singh, M., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100717 · Cited by 19
Ede, B. C., Asmaro, R. R., Moppett, J. P., Diamanti, P., & Blair, A. (2018) · Haematologica · doi:10.3324/haematol.2017.186700 · Cited by 18
Doron, B., Handu, M., & Kurre, P. (2017) · Stem Cells · doi:10.1002/stem.2761 · Cited by 17
Endothelial cell–leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilities
Cappelli, L. V., Fiore, D., Phillip, J. M., Yoffe, L., Giacomo, F. D., Chiu, W., Hu, Y., Kayembe, C., Ginsberg, M. D., Consolino, L., et al. (2022) · Blood · doi:10.1182/blood.2022015414 · Cited by 17
Driving CAR T Stem Cell Targeting in Acute Myeloid Leukemia: The Roads to Success
Michelozzi, I. M., Kirtsios, E., & Giustacchini, A. (2021) · Cancers · doi:10.3390/cancers13112816 · Cited by 17
Kunisaki, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11093-2_6 · Cited by 18
In Vitro 3D Models of Haematological Malignancies: Current Trends and the Road Ahead?
Mattioda, C., Voena, C., Ciardelli, G., & Mattu, C. (2025) · Cells · doi:10.3390/cells14010038 · Cited by 18
Metadata
- Authors
- Duan, C.-W., Shi, J., Chen, J., Wang, B., Yu, Y.-H., Qin, X., Zhou, X.-C., Cai, Y.-J., Li, Z.-Q., Zhang, F., Yin, M.-Z., Tao, Y., Mi, J.-Q., Li, L.-H., Enver, T., Chen, G.-Q., & Hong, D.-L.
- Affiliations
- Shanghai Jiao Tong University (CN)
- University College London (GB)
- Corresponding author
- Enver, Tariq
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 25
- Issue
- 6
- Pages
- 778-793
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2094470615
- Cited by
- 198
- References
- 36
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 9 · 2023: 18 · 2022: 16 · 2021: 16 · 2020: 17 · 2019: 13 · 2018: 30 · 2017: 22 · 2016: 16 · 2015: 18 · 2014: 5
- FWCI
- 20.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Cancer Research UK (12796)
- Topics
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- acute lymphoblastic leukemia, leukemia microenvironment, bone marrow microenvironment, chemoresistance, niche formation, supporting cells, induction therapy, mouse transplantation model
- MeSH terms
- Animals, Antineoplastic Combined Chemotherapy Protocols, Biopsy, Bone Marrow Cells, Cytarabine, Daunorubicin, Disease Models, Animal, Humans, Neoplastic Stem Cells, Mice, SCID, Mice, Inbred NOD, Xenograft Model Antitumor Assays, Mice, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Stem Cell Niche, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review